CAR-t cell National meeting at Kochi on 6th April Arjun D. Law Lingaraj Nayak ImmunoACT AmalaOncology Princess Margaret Cancer Centre

Our recent publication in The Lancet Hematology highlights the clinical trials data on registration trial for NexCAR19 (73%ORR, no ICANS, minimal CRS) and it's access to LMICs ImmunoACT Rahul Purwar

Our Co-founder & Head-Scientific programs, Dr. Atharva Karulkar shared the journey of India’s 1st indigenous CAR-T therapy, NexCAR19, at #GATC2025, inspiring discussions on innovation and impact in healthcare. #ImmunoACT #NexCAR19 #IISERPune #CancerTreatment

We encourage you to join today’s insightful sessions and be a part of the ongoing dialogue shaping the future of healthcare!! #ImmunoACT #NexCAR19 #CARTSummit2025 Rahul Purwar shirish arya Hasmukh Jain Tata Memorial Hospital ACTREC-TMC Atharva Karulkar shreshtha shah

We're proud to lead India's journey in making CAR-T cell therapy more accessible for patients across the world. This article by Moneycontrol highlights how India is becoming a destination for international patients seeking CAR-T therapy - bolstered by its affordability,

𝗠𝗮𝗸𝗶𝗻𝗴 𝗖𝗔𝗥-𝗧 𝗔𝗰𝗰𝗲𝘀𝘀𝗶𝗯𝗹𝗲: 𝗗𝗿. 𝗥𝗮𝗵𝘂𝗹 𝗣𝘂𝗿𝘄𝗮𝗿’𝘀 𝗩𝗶𝘀𝗶𝗼𝗻 𝗳𝗼𝗿 𝗜𝗻𝗱𝗶𝗮’𝘀 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗙𝘂𝘁𝘂𝗿𝗲 At #CARTSummit2025, Dr. Rahul Purwar (Our Founder and IIT-B Professor) brought a powerful message of purpose, accessibility, and

At #CARTSummit2025, Dr. Jitendra Kumar, Managing Director at Biotechnology Industry Research Assistance Council (BIRAC), delivered a powerful session on enabling India’s CAR-T landscape through strategic support and innovation. He highlighted BIRAC’s pivotal role in bridging

2012 a friend said- “Science Fiction” 2015 we dared to dream Sharing 🇮🇳 1st novel #CARTCellRx Ph 1/1b trial We report 92% ORR 3 dose levels nature Blood Cancer Journal Rahul Purwar ImmunoACT CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC Nirali Shah Tata Memorial Hospital Swaminathan K Alka Dwivedi rdcu.be/ei7xh

Exciting milestone in CAR T Cell Therapy for pediatric patients!!! rdcu.be/ei7xh Gaurav Narula MD Albeena Nisar deepalipandit1993 Rahul Purwar Atharva Karulkar Tata Memorial Hospital ACTREC-TMC IIT Bombay ImmunoACT

At #CARTSummit2025, Dr. Sattva Neelapu delivered an insightful session on the evolving landscape of CAR T-cell therapy. In his talk, “Current Status of CAR-T cell therapy in r/r B-NHLs treatment” he walked attendees through international trial data in B-LBCLs, emphasizing the

We’re proud to share that our Co-founder and Head of Scientific Programs, Dr. Atharva Karulkar, paneled a session at the World Health Summit Regional Meeting 2025 in New Delhi. Dr. Karulkar was invited to share his insights during a thought-provoking session titled "How to

At #CARTSummit2025, Dr. Rajeev Raghuvanshi, Drugs Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO), delivered a forward-looking session titled “Advanced Healthcare: Can India Lead the Way for Cell and Gene Therapy in the Next Decade?” He

Durable, deep, and life-changing – Our CAR-T cell therapy (NexCAR19) continues to demonstrate real-world impact. We’re proud to see our first patient at Aster MIMS still in remission months after treatment. Durability isn't just a clinical metric, it's a second chance at life.

At #CARTSummit2025, Ms. Shalini Jatia, Officer in Charge at ImPaCCT Foundation, Tata Memorial Centre, led a powerful session titled “Patient Journey: Learning the Patient's Journey in the Patient's Own Voice.” The session brought to the stage eight CAR-T therapy recipients who

Thanks to Department of Biotechnology DBT-BIRAC and Dr Gokhale for highlighting the CAR-T as science with compassion, access and affordability. We will continue to work hard to improve access of such high quality-life saving medicines at affordable cost. Dr Jitendra Singh IIT Bombay ImmunoACT

At #CARTSummit2025, the session titled “Bridging the Gap - Role of NGOs and CSR in Providing Intent-to-Cure Solutions for Cancer Care” brought together experts from healthcare and the development sector to address access challenges in cancer treatment. Moderated by Ms. Sunita

Grateful to Technology Development Board and Dr. Rajesh Gokhale for highlighting India’s biotech progress. We're proud to contribute to the journey with our indigenous CAR-T cell therapy - making advanced cancer care more accessible and affordable. #NTD2025 #ImmunoACT #MakeInIndia #NexCAR19

We are honored to share the journey of Korak Abdulla Muhamad, the first patient from Yatharth Super Speciality Hospitals to receive #NexCAR19. In this inspiring testimonial, Korak reflects on his recovery from relapsed blood cancer through CAR-T cell therapy. Congratulations to

Dr. Rahul Purwar, Founder, ImmunoACT and Prof. at IIT Bombay referenced the journey behind NexCAR19- India's first #CAR-T cell therapy. Supported by strong global & academic partnerships, the therapy is now saving lives at a fraction of global costs, across 70+ hospitals.

We are happy to share that Dr. Sushant Kumar, Senior Scientist at #ImmunoACT, recently delivered an inspiring lecture at IIT Bombay to the National-level winners of Vidyarthi Vigyan Manthan (VVM) - India’s premier science talent program for VI-XI school students. His talk,